DRI vs REGN · P/E 22, rev $12.08B vs P/E 14, rev $14.34B
Darden Restaurants Inc (DRI) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Darden Restaurants Inc (DRI) is a restaurants company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported DRI revenue for 2025-05-25 was $12.08B. Net income was $1.05B. Revenue was up 6.0% from 2024-05-26 to 2025-05-25. DRI currently screens at market cap $24.20B and trailing P/E 22.3.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
DRI currently screens at market cap $24.20B and trailing P/E 22.3. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the DRI and REGN stock pages for the full models.
Not investment advice.